Edition:
United States

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

15.07USD
17 Dec 2018
Change (% chg)

-- (--)
Prev Close
$15.07
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
227,692
52-wk High
$17.93
52-wk Low
$4.24

Chart for

About

Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from... (more)

Overall

Beta: 1.97
Market Cap(Mil.): $876.81
Shares Outstanding(Mil.): 64.52
Dividend: --
Yield (%): --

Financials

  FATE.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -1.23 -- --
ROI: -48.47 0.60 13.80
ROE: -57.42 -2.18 15.29

Earnings vs. Estimates